NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis (PsO) submitted to U.S. FDA in July ...

Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its second quarter 2025 results on Wednesday, August 13, 2025, after market close. The announcement will be followed by an ...

The company's revenue (GAAP) reached $21.2 million, up from $15.3 million in Q2 2024, outpacing the analyst consensus of $20.45 million (GAAP). Earnings per share (EPS, GAAP) were $(0.38), also better ...

Auctus maintains 30c price target as ADX exceeds production targets for Q4 FY2025 Key price short term catalyst is the ...

Live Updates Live Coverage Updates appear automatically as they are published. How DraftKings Stock Performed After Past ...